
ACC 21 Highlights: Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction. Results of the LIFE Trial
By
Yale School of Medicine
FEATURING
Tariq Ahmad
June 14, 2021
Login to view comments.
Click here to Login